The U.S. Food and Drug Administration (FDA) has approved the t:slim X2 insulin pump with Basal-IQ technology from Tandem Diabetes Care. Basal-IQ is a predictive
Tandem Diabetes Care, the medical device company and manufacturer of the only touchscreen insulin pumps available in the US has entered into a distribution agreement